GlaxoSmithKline announces Dr. Anne Beal to its Board as Non-Executive Director

– UK, Brentford –  GlaxoSmithKline plc (LON: GSK | NYSE: GSK) today announced the appointment of Dr. Anne Beal to its Board as a Non-Executive Director, effective from 6 May 2021.

She will become a member of the Corporate Responsibility Committee which provides important oversight of the Company’s Trust agenda including policies towards access to medicines, global health, inclusion and diversity, and environmental sustainability. Dr. Beal will succeed Lynn Elsenhans as Chair of the Committee after the 2022 AGM.

“I am delighted to welcome Anne to GSK. Acting responsibly is an integral part of how successful modern businesses deliver for a wide range of stakeholders including investors. That’s why the work of the Corporate Responsibility Committee is critical to the success of GSK. Anne’s expertise and experience will be a valuable addition to GSK and to the leadership of the Committee. I would like to thank Lynn for her service to the Company over the last nine years and to agreeing to stay on to ensure a smooth transition to Anne.” said Board Chairman, Sir Jonathan Symonds.

Dr. Beal will bring to GSK extensive healthcare experience as a physician and entrepreneur combined with a passion for patient advocacy. She is a recognized health policy expert in the development of global and national programs for improving healthcare access for all patient groups and in ensuring the voice of patients is reflected in research programs.

About Dr. Anne Beal

Dr. Anne Beal is the founder and CEO of AbsoluteJOI Skincare and a member of the Board of AcademyHealth. Before her current roles, Dr. Beal spent six years at Harvard Medical School and Massachusetts General Hospital, where she was an instructor in pediatrics and has also held leadership roles at the Commonwealth Fund and the Aetna Foundation. Dr. Anne Beal was previously Deputy Executive Director and Chief Engagement Officer for The Patient-Centered Outcomes Research Institute in the U.S. and Chief Patient Officer and Global Head of Patient Solutions at Sanofi.

She holds a B.A. from Brown University, an M.D. from Cornell University Medical College, and an M.P.H. from Columbia University.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.